Sort
82,697 grants matching “vaccine development”
Systems Biology Approaches to Viral Pathogenesis and Immunity
$976,964Michael G Katze · Oregon Health & Science University · U54 · FY2012 · AI
Vaccine Platforms
$976,949Ronald G Crystal · Wadsworth Center · U54 · FY2008 · AI
Evaluation and Production of a Multivalent Adenoviral Plague Vaccine
$976,943Eric Rothe · Norwell, Inc. · R44 · FY2013 · AI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$976,790Shabaana A. Khader · Washington University · R01 · FY2018 · AI
Low cost molecular assay for HIV
$976,790Bertrand Lemieux · Biohelix Corporation · R44 · FY2010 · AI
Immunopharmacotherapy for Mitigating Opioid Addiction
$976,653Kim D Janda · Scripps Research Institute, The · UH3 · FY2017 · DA
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
$976,570Judith S. Currier · University Of California Los Angeles · UM1 · FY2025 · AI
Nonclinical Development of an Improved Polio Vaccine
$976,542Gregory John Tobin · Biological Mimetics, Inc. · R44 · FY2023 · AI
University of Pittsburgh Clinical and Translational Science Institute
$976,487Steven E Reis · University Of Pittsburgh At Pittsburgh · UL1 · FY2021 · TR
Monoclonal antibody isolation and characterization
$976,284Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Therapeutics that target processivity complex proteins of pox and other viruses
$976,136Robert Paul Ricciardi · University Of Pennsylvania · U01 · FY2011 · AI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$976,050Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Developing small molecule therapeutics for Ebola hemorrhagic fever virus
$976,031Arnab Basu · Microbiotix, Inc · R01 · FY2010 · AI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
$975,965John Adams · University Of South Florida · U01 · FY2022 · AI
Development of a Technology Platform for Engineering Single-Administration HIV Therapeutics
$975,928Leor S Weinberger · J. David Gladstone Institutes · R56 · FY2019 · AI
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
$975,920Jonah B. Sacha · Oregon Health & Science University · R01 · FY2023 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine
$975,729Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2019 · AI
COVID-19 Treatment Cascade Optimization Study
$975,705Liliane Cambraia Windsor · University Of Illinois At Urbana-Champaign · U01 · FY2022 · AI
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$975,704Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Therapeutics that target processivity complex proteins of pox and other viruses
$975,696Robert Paul Ricciardi · University Of Pennsylvania · U01 · FY2012 · AI
Administrative Core - Galveston National Laboratory BSL4 Operations
$975,682James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2017 · AI
Evaluation fo Live Attenuated B. Melitensis Vaccines in Nonhuman Primates
$975,633Thomas A Ficht · University Of Texas Med Br Galveston · U54 · FY2012 · AI
Enhanced Oral Vaccine Delivery Vehicle
$975,540Sean N Tucker · Vaxart, Inc. · R44 · FY2011 · AI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
$975,499John Adams · University Of South Florida · U01 · FY2023 · AI
Shigella Live Vector-Based Multivalent Vaccine
$975,452Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2015 · AI